The potential market for the drugs continues to grow, with an estimated 50% of Americans predicted to be obese by 2030.[5] The good news is that self-funding your employee health plan can be a smart decision for companies facing rising health care costs
Your body naturally produces GLP-1 in the gut, especially after eating
The REVOLUTION study, Diabetes Epidemiology and Management (2024) Efficacy of semaglutide in a subcutaneous and oral formulation, Frontiers in Endocrinology (2021) Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial, Nature Medicine (2022) Real-world use of oral versus subcutaneous semaglutide in a cohort of Type 2 diabetic patients: which option to which patient?, Journal of Endocrinological Investigation (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, FDA.gov (2024) Dietary supplements for weight loss, National Institutes of Health Evaluation of efficacy and safety of orlistat in obese patients, Indian Journal of Endocrinology and Metabolism (2011) A systematic review of dietary supplements and alternative therapies for weight loss, Obesity (2021) Are weight loss supplements safe?, Poison Control Tainted weight loss products, FDA.gov Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
If youre curious about adding peptides to your haircare routine, you may be interested in learning how, exactly, they work
Micah Eimer, an internist who has followed prescribing patterns in this drug class closely, has flagged the risk of hypotensive effects in older patients
Beikoghli Kalkhoran S, Kararigas G
